Carcell BioPharma Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Carcell BioPharma General Information

Description

Developer of biopharmaceutical platforms intended to promote next-generation cell and gene therapies. The company's platforms focus on engineered red blood cells for immune regulation and non-viral vector gene delivery based on lipid nanoparticles, committing to accelerating the discovery and development of next-generation cell and gene therapies.

Contact Information

Website
www.carcell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building 122
  • No. 166 Meiyue Road, China Free Trade Pilot Zone
  • Shanghai, 201208
  • China
+86 021
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Delivery
Vertical(s)
Life Sciences
Corporate Office
  • 2nd Floor, Building 122
  • No. 166 Meiyue Road, China Free Trade Pilot Zone
  • Shanghai, 201208
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carcell BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 13-Nov-2023 Completed Clinical Trials - General
2. Seed Round 02-Nov-2021 Completed Startup
1. Accelerator/Incubator 25-Aug-2021 Completed Startup
To view Carcell BioPharma’s complete valuation and funding history, request access »

Carcell BioPharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wuxi Capital Group Venture Capital Minority
BioTrack Capital Venture Capital Minority
Hyfinity Investments Growth/Expansion Minority
Legend Star Corporate Venture Capital Minority
EVX Ventures Venture Capital Minority
To view Carcell BioPharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Carcell BioPharma FAQs

  • When was Carcell BioPharma founded?

    Carcell BioPharma was founded in 2021.

  • Where is Carcell BioPharma headquartered?

    Carcell BioPharma is headquartered in Shanghai, China.

  • What industry is Carcell BioPharma in?

    Carcell BioPharma’s primary industry is Discovery Tools (Healthcare).

  • Is Carcell BioPharma a private or public company?

    Carcell BioPharma is a Private company.

  • What is Carcell BioPharma’s current revenue?

    The current revenue for Carcell BioPharma is .

  • How much funding has Carcell BioPharma raised over time?

    Carcell BioPharma has raised $15.6M.

  • Who are Carcell BioPharma’s investors?

    Wuxi Capital Group, BioTrack Capital, Hyfinity Investments, Legend Star, and EVX Ventures have invested in Carcell BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process